Skip to main content
. 2013 Oct 22;6:163–174. doi: 10.2147/IDR.S51340

Table 3.

Minimum inhibitory concentrations of isavuconazole and selected antifungal agents for 50% and 90% (MIC50 and MIC90, respectively) of Aspergillus spp. isolates.18

Pathogen Antifungal agent MIC50 (μg/mL) MIC90 (μg/mL)
Aspergillus fumigatus Isavuconazole 0.25–1 0.5–2
Voriconazole 0.25–1 0.5–2
Caspofungin 0.06–0.5 0.06–0.5
Amphotericin B 0.25–4 0.5–8
Aspergillus terreus Isavuconazole 0.5–1 0.5–4
Voriconazole 0.25–1 0.5–2
Caspofungin 0.03–0.5 0.06–0.5
Amphotericin B 1–4 1–8
Aspergillus flavus Isavuconazole 0.5–2 1–16
Voriconazole 0.5–1 0.5–2
Caspofungin 0.03–0.25 0.03–0.25
Amphotericin B 1–2 1–4
Aspergillus niger Isavuconazole 0.5–2 2–4
Voriconazole 0.25–2 1–2
Caspofungin 0.06–0.25 0.125–0.25
Amphotericin B 0.5–1 0.5–2

Note: Copyright © 2010, Springer Science and Business Media. Adapted with permission from Thompson GR III, Wiederhold NP. Isavuconazole: a comprehensive review of spectrum of activity of a new triazole. Mycopathologia. 2010;170(5):291–313.18

Abbreviation: MIC, minimum inhibitory concentration.